No additional benefit of prescribing a very low-protein diet in patients with advanced chronic kidney disease under regular nephrology care: a pragmatic, randomized, controlled trial.
Vincenzo BellizziSimona SignorielloRoberto MinutoloBiagio Di IorioPaola NazzaroCarlo GarofaloPatrizia CalellaPaolo ChiodiniLuca De Nicolanull nullPublished in: The American journal of clinical nutrition (2022)
This long-term pragmatic trial found that in patients with CKD under stable nephrology care, adherence to protein restriction is low. Prescribing sVLPD compared with standard LPD is safe but does not provide additional advantage to the kidney or patient survival.
Keyphrases
- study protocol
- chronic kidney disease
- randomized controlled trial
- primary care
- healthcare
- palliative care
- end stage renal disease
- quality improvement
- protein protein
- clinical trial
- amino acid
- pain management
- binding protein
- affordable care act
- adverse drug
- open label
- emergency department
- type diabetes
- phase iii
- phase ii
- metabolic syndrome
- skeletal muscle
- glycemic control